Dimethyl Fumarate Versus Teriflunomide for Relapsing MS Dimethyl Fumarate Versus Teriflunomide for Relapsing MS

Time to confirmed disability worsening was longer in patients who received dimethyl fumarate, compared with those who received teriflunomide, in an analysis of real-world data.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news